AU2002211776A1 - A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes - Google Patents

A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes

Info

Publication number
AU2002211776A1
AU2002211776A1 AU2002211776A AU1177602A AU2002211776A1 AU 2002211776 A1 AU2002211776 A1 AU 2002211776A1 AU 2002211776 A AU2002211776 A AU 2002211776A AU 1177602 A AU1177602 A AU 1177602A AU 2002211776 A1 AU2002211776 A1 AU 2002211776A1
Authority
AU
Australia
Prior art keywords
retinamide
liposomes
hydroxyphenyl
incorporate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211776A
Inventor
Soo-Jeong Lim
Gabriel Lopez-Berestein
Ana Maria Tari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU2002211776A1 publication Critical patent/AU2002211776A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002211776A 2000-10-17 2001-10-17 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes Abandoned AU2002211776A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24144500P 2000-10-17 2000-10-17
US60/241,445 2000-10-17
PCT/US2001/032310 WO2002032413A2 (en) 2000-10-17 2001-10-17 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes

Publications (1)

Publication Number Publication Date
AU2002211776A1 true AU2002211776A1 (en) 2002-04-29

Family

ID=22910729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211776A Abandoned AU2002211776A1 (en) 2000-10-17 2001-10-17 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes

Country Status (5)

Country Link
US (1) US20020143062A1 (en)
EP (1) EP1328262A2 (en)
AU (1) AU2002211776A1 (en)
CA (1) CA2425196A1 (en)
WO (1) WO2002032413A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4384409B2 (en) * 2000-12-05 2009-12-16 チルドレンズ・ホスピタル・ロス・アンジエルス Pharmaceutical composition of fenretinide with increased bioavailability and method of use thereof
CA2509955A1 (en) * 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
MXPA05008138A (en) * 2003-01-31 2006-02-17 Los Angeles Childrens Hospital Oral compositions of fenretinide having increased bioavailability and methods of using the same.
GEP20084520B (en) 2004-06-23 2008-10-27 Sirion Therapeutics Inc Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases
WO2006047475A2 (en) * 2004-10-25 2006-05-04 Sytera, Inc. Detection and analysis of ophthalmically-relevant fluorescent molecules
AU2005304822B2 (en) * 2004-11-04 2008-10-16 Sirion Therapeutics, Inc. Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation
DK2727583T3 (en) 2004-12-22 2021-12-20 Nitto Denko Corp Drug carrier and drug carrier kit for inhibiting fibrosis
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
JP2008536874A (en) 2005-04-15 2008-09-11 ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム Delivery of siRNA by neutral lipid composition
CA2912259C (en) 2005-05-27 2020-04-28 Mark H. Schoenfisch Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
UA81382C2 (en) * 2005-07-11 2007-12-25 Composition for treating retinol-related diseases by modulation of retinol binding
JP5342834B2 (en) * 2008-09-05 2013-11-13 日東電工株式会社 Treatment agent for myelofibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
JP5113038B2 (en) * 2006-03-23 2013-01-09 テムリック株式会社 Cancer treatment kit and pharmaceutical composition for cancer treatment
NZ572601A (en) 2006-03-29 2012-03-30 Univ Wayne State Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
US20080025972A1 (en) * 2006-07-26 2008-01-31 Duke University Treating sex steriod responsive disorders
TWI407971B (en) 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
EP2467127B1 (en) 2009-08-21 2023-08-02 Novan, Inc. Topical gels
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
RU2016122918A (en) * 2013-12-23 2018-01-30 Дэрмопартнерс, С.Л. METHOD FOR PRODUCING RETINALDEHYDE OR OTHER REDINAL ACID AND OTHER PRODUCED THIS PRODUCT BY LIPOS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
JP3691054B2 (en) * 1992-01-16 2005-08-31 ボード、オブ、リージェンツ、ザ、ユニバーシティー、オブ、テキサス、システム Formulation and use of carotenoids in the treatment of cancer
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders

Also Published As

Publication number Publication date
US20020143062A1 (en) 2002-10-03
CA2425196A1 (en) 2002-04-25
WO2002032413A2 (en) 2002-04-25
EP1328262A2 (en) 2003-07-23
WO2002032413A3 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
AU2002211776A1 (en) A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
AU2001232210A1 (en) Scheduling in a remote-access server
AU2001259059A1 (en) Beta-glucans encapsulated in liposomes
AU2446499A (en) A method relating to databases
GB0026222D0 (en) Improvements in or relating to a head-up display
AUPQ683100A0 (en) A method and system for advertising to a user
GB2385703B (en) A sign
AU2002216596A1 (en) Method relating to positioning of a mobile device
AU9361301A (en) A new two-cycle engine
GB2360322B (en) Improvements relating to fasteners
AUPQ782400A0 (en) A sleep study apparatus
AU2001285396A1 (en) A magnetic head
AU2002211168A1 (en) Method and arrangement relating to retrieving position information
GB0005245D0 (en) Improvements in or relating to a razor
AU2001244145A1 (en) Flat element and method for producing a flat element
AU2001290111A1 (en) Instruction issue in a processor
AU2001289135A1 (en) Techniques to implement one-dimensional compression
AU5896201A (en) A method to measure surface structure
AU2001243691A1 (en) A hydrating system
AU2002309389A1 (en) Improvements in or relating to a pole
AU2001284595A1 (en) A casing and a method to produce the same
AU2001260200A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amides
AU2002301555A1 (en) A frame member
AU2001274704A1 (en) Methods and arrangements relating to a telecommunication system
GB0010961D0 (en) Improvements in or relating to a connection